We envisage future studies that probe this complex interaction in mammalian cells, possibly in the hope of identifying novel ways to inhibit RNR in cancer, feasible given the role of DNAJA1 and other co-chaperones in anticancer drug resistance [65, 66]. This evidence concerns the gene NR2E3 and cancer.